These results are partially consistent with previous work conducted by Meudec et al. [17], as they also observed a decrease in the in vitro expression of NKp30; however, while in their case, the biggest decrease was found in tofa and upa, we did find a decrease in the tofa group but not in the upa one, which, in our case, was higher among the JAKi group and at the level of the RA control groups. This evidence concerns the gene NCR3 and rheumatoid arthritis.